Neupogen Injectable Drug Recalled for Potential Stability Issues at Expiration
Amgen is recalling Neupogen (filgrastim) injectable vials due to stability concerns. Stability data indicates the product may be out of specification at its expiration date.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II recall for a drug that may be out of specification at expiry, representing a risk-of-harm product where patients could receive ineffective medication for serious conditions. No illnesses, injuries, or deaths have been reported, capping severity at High per the rubric.
Plain-English summary
Amgen, Inc. is recalling Neupogen (filgrastim) For Injection, 300mcg/1 mL, in 1 mL single-dose vials. The recall affects multiple lot numbers with expiration dates ranging from February 2025 to July 2027.
Stability data does not support the current expiration dates. The products have the potential to be out of specification at the time of expiry, meaning they may not maintain their intended potency and effectiveness through the labeled expiration date.
This recall affects Neupogen distributed nationwide in the United States and multiple international markets. Approximately 313,620 vials have been distributed. Healthcare providers and patients should stop using affected lot numbers immediately and contact their pharmaceutical supplier or Amgen to arrange for replacement medication.
The recalled product
- Product
- NEUPOGEN (FILGRASTIM)
- Brand
- NEUPOGEN
- Manufacturer
- Amgen, Inc.
- Category
- Drug — Injectable
- Hazard
- stability-degradation
- potency-loss
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 1147300
- 1147300A
- Exp.: 2/28/2025
- 1152064
- Exp.:3/31/2025
- 1154734
- 1156806
- Exp.: 8/31/2025
- 1159109
- Exp.: 10/31/2025
- 1163909
- Exp.: 2/28/2026
- 1164631
- Exp.: 5/31/2026
- 1171366
- 1182097
- Exp.:8/31/2026
- 1176114
- Exp.: 2/28/2027
- 1182094
UPCs (2)
- 0355513530101
- 0355513546102
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NEUPOGEN
- HighInjectable Drug Recalled for Stability Issues at Expiration
FDA (Drugs) · 2025-03-26
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27